Celldex to Present at Upcoming Investor Conference
Rhea-AI Summary
Celldex (NASDAQ:CLDX) management will appear in a fireside chat at H.C. Wainwright’s 4th Annual Inflammatory Skin Disease Virtual Conference on April 14, 2026 at 3:30 pm ET. The live webcast will be available in the Investors > Events & Presentations section and replays will remain for 90 days.
Positive
- None.
Negative
- None.
News Market Reaction – CLDX
On the day this news was published, CLDX gained 2.27%, reflecting a moderate positive market reaction. This price movement added approximately $57M to the company's valuation, bringing the market cap to $2.56B at that time.
Data tracked by StockTitan Argus on the day of publication.
HAMPTON, N.J., April 13, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in a fireside chat at H.C. Wainwright’s 4th Annual Inflammatory Skin Disease Virtual Conference on Tuesday, April 14 at 3:30 pm ET.
The webcast of the presentations will be available on the "Events & Presentations" page of the "Investors" section of the Celldex website. Replays will be available for 90 days following the event.
About Celldex
Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders.
Visit www.celldex.com.
Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com
Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com